Skip to main content
Home
Knowledge Base
for the National TB Elimination Program - NTEP

Main navigation

  • Home
    • About Us
  • Curriculum
    • Search Courses
  • Knowledge Map
    • Knowledge Map Summary
  • Page Library
    • Content Page Summary
    • Translations
  • Documents

Search

Published on LMS

  1. Home
  2. Published on LMS

Content Status where content has been uploaded and published on LMS.

State PMDT Committee: Terms of Reference [ToR]

H5Content

Common or Relevant Adverse Effects of DR-TB Therapy​

H5Content

Immune Reconstitution Inflammatory Syndrome [IRIS]

H5Content

DR-TB Treatment in Pregnancy: General Considerations​

H5Content

Shorter Injectable-containing MDR/RR-TB Regimen: Pre-treatment evaluation and follow-up​

H5Content

Pre-treatment Evaluation [PTE] of DR-TB Patients​

H5Content

Key Messages for TB Counselling​

H5Content

Components of Drug Resistant TB Counselling Tool

H5Content

Bedaquiline Drug Dosages and Duration

H5Content

Eligibility Criteria for the Use of Bedaquiline [Bdq] in MDR/RR-TB Treatment​

H5Content

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 114
  • Page 115
  • Page 116
  • Page 117
  • Page 118
  • Page 119
  • Page 120
  • Page 121
  • Page 122
  • …
  • Next page ››
  • Last page Last »
Subscribe to Published on LMS

User account menu

  • Log in

This work is licensed under Attribution-NonCommercial 4.0 International